
A silicone used in a medical device must be suitable for its intended application: Crucial factors are contact with the body, exposure, and the condition of the finished product. A positive material test report is an important component in this process. However, the evaluation also includes manufacturing, additives, purification, and, if applicable, sterilization.
What question does the biological assessment answer?
Biological evaluation examines the risks that a product may pose through contact with the body during its intended use. ISO 10993-1 integrates this evaluation into risk management. The 2025 edition explicitly emphasizes the link to ISO 14971. The information and investigations required depend on the application and the available evidence.
Describe the application before selecting the material
To make a reliable inquiry, development and quality management should first compile the following information:
- Which body tissue does the product directly or indirectly touch?
- How long and how frequently does the contact take place?
- In what state is the material used: unaltered, pigmented, coated, or combined with other materials?
- What cleaning, disinfection, sterilization, and reuse procedures are planned?
- For which markets and intended purpose is the finished product being developed?
This allows verification that the existing documentation covers the same exposure and material condition.
Read product-related test reports
A test report must include the exact material designation, the tested sample, its manufacturing process, and the biological endpoints examined. It must also clarify whether additives and subsequent processing steps have already been taken into account. The FDA requires justification if the test sample differs from the finished medical device. Therefore, a summary in the data sheet does not replace a review of the complete documentation.
One example is the manufacturer's grades ZA SFX 0020 and ZA SFX 10 WT 10: Zhermack publishes biological studies on these materials for defined contact conditions. This is a concrete statement about these materials and the respective studies. It cannot be extrapolated to another silicone simply because of a similar name or the same crosslinking method.
What do ISO 10993 and USP Class VI mean?
ISO 10993 refers to a series of standards for biological evaluation. The designation should be specified by the tested part, the version used, the report, and the contact conditions. Even with a designation of "USP Class VI," the underlying report must be reviewed: the test specimen, the version used, and the scope of the investigation must be appropriate to the question being addressed. Such a designation does not constitute a general approval for a finished medical device.
Bringing together material, process and finished product
Changing a pigment, release agent, or sterilization method can alter the relevant residues and exposures. Such changes must be included in the assessment. A general post-temperature instruction for all silicones would be unsuitable: The procedure must be tailored to the specific material, component, and manufacturing process.
In Switzerland, medical devices do not undergo the same regulatory approval process as pharmaceuticals, according to Swissmedic. The applicable conformity assessment procedure is decisive. The biological evaluation is part of the technical assessment of the product.
Documents for the material request
A brief description of the application, the intended contact conditions, the manufacturing process, and the required documentation are helpful. This allows for a targeted comparison of suitable material grades and the corresponding manufacturer's documentation.
Further resources
The current product documentation is decisive for processing.